ライフサイエンスコーパス: hypopharynx

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 sites: oral tongue, oropharynx, larynx, and hypopharynx.

2 th squamous cell carcinoma of the larynx and hypopharynx.

3 split around the larynx and rejoined in the hypopharynx.

4 entation of transverse cine MR images of the hypopharynx aids in quantification of increased airway w

5 tubes are percutaneously placed through the hypopharynx and directed into the stomach or small bowel

6 Before the 1990s, hypopharynx and oropharynx cancers carried the highest e

7 leading to direct communication between the hypopharynx and the mediastinum.

8 x subjects we also recorded pressures in the hypopharynx and upper oesophagus.

9 ll carcinoma of the oral cavity, oropharynx, hypopharynx, and larynx treated with definitive surgery

10 PC, -1.23; 95% CI, -1.84 to -0.62; P = .001; hypopharynx: APC, -2.44; 95% CI, -3.01 to -1.86; P < .00

11 Aspirates from the hypopharynx at age 4 weeks were cultured for Streptococc

12 iration, colored water was perfused into the hypopharynx at the rate of 1 mL/min.

13 volume of water that can safely dwell in the hypopharynx before spilling into the larynx (Hypopharyng

14 inverse associations with risk of larynx and hypopharynx cancer combined (OR 0.55, 95CI% 0.39-0.78) a

15 ed; 37 had base of tongue cancer, and 22 had hypopharynx cancer.

16 etaxel in Patients With T3 and T4 Larynx and Hypopharynx Carcinoma]).

17 by premature spillage of oral fluid into the hypopharynx, delayed clearance of fluid from the hypopha

18 ral cancers, 135 oropharynx cancers, and 247 hypopharynx/larynx cancers) and 300 patients with esopha

19 obacco-related cancers (larynx, oral cavity, hypopharynx, lung) and an HPV-related cancer (anus).

20 ere often seen in the nasopharynx and in the hypopharynx of asymptomatic sleeping children.

21 pharynx, delayed clearance of fluid from the hypopharynx, or excessive hypopharyngeal pressure genera

22 ll carcinoma of the oral cavity, oropharynx, hypopharynx, or larynx undergoing first-line curative tr

23 Patients with LASCCHN of the oropharynx, hypopharynx, or larynx with measurable disease were rand

24 ll established in cancer of the oral cavity, hypopharynx, or larynx, collectively referred as non-OPS

25 wn carcinoma of the oral cavity, oropharynx, hypopharynx, or larynx.

26 ay diameter of the nasopharynx (P <.001) and hypopharynx (P <.001).

27 in the nasopharynx (P <.006) but not in the hypopharynx (P =.655).

28 stage (odds ratio, 3.07; P = .0036); larynx/hypopharynx primary site (odds ratio, 4.17; P = .0041);

29 Older age, advanced T-stage, and larynx/hypopharynx primary site were strong independent risk fa

30 The hypopharynx showed dynamic motion in 72 (49%) of the pat

31 : nasopharynx SP (P <.001) and IC (P <.001); hypopharynx SP (P <.001) and IC (P <.001); and mean chan

32 UM-SCC-22A cells (squamous cell carcinoma of hypopharynx) via overexpression of mammalian upstream re

33 Motion of the nasopharynx, oropharynx, and hypopharynx was characterized as static patent, dynamic

34 However, collapse of the hypopharynx was not normally encountered.

35 The nasopharynx, oropharynx, and hypopharynx were characterized in terms of airway motion

36 carcinoma of the oral cavity, oropharynx, or hypopharynx were eligible.

37 rse fast gradient-echo cine MR images of the hypopharynx were obtained at 1.5 T in 31 children with O

38 Colonization of the hypopharynx with M. catarrhalis, S. pneumoniae, H. influ

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。